Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
35,359,061
-
Share change
-
-3,986,455
-
Total reported value
-
$5,149,559,679
-
Put/Call ratio
-
163%
-
Price per share
-
$145.60
-
Number of holders
-
890
-
Value change
-
-$572,938,906
-
Number of buys
-
307
-
Number of sells
-
385
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2024
As of 30 Sep 2024,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
890 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,359,061 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, CITIGROUP INC, Royal Bank of Canada, JANE STREET GROUP, LLC, GOLDMAN SACHS GROUP INC, UBS Group AG, WELLS FARGO & COMPANY/MN, and COMMERCE BANK.
This page lists
885
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.